Stender S, Hjelms E
Scand J Clin Lab Invest Suppl. 1987;186:21-9.
It has recently become possible to measure the in vivo flux of cholesteryl ester from plasma into human aortic tissue by use of labeled cholesterol in patients undergoing reconstructive aortic surgery. For the ascending thoracic aorta without visible atherosclerotic lesions the influx was 4.5 +/- 1.4 nmol X cm-2 X day-1 (means +/- SEM, n = 9). For the abdominal aorta with severe atherosclerosis the influx of cholesteryl ester was 45 +/- 5 nmol X cm-2 X day-1 (n = 12). In both types of tissues the influx of cholesteryl ester from HDL was 2-3 times higher than the influx of cholesteryl ester from LDL and VLDL compared with the concentration of these fractions in plasma. This is in accordance with an aortic influx-mechanism which depends on the sizes and the concentration of the lipoproteins in plasma. The transfer of plasma lipoproteins into human aortic tissue shows a number of similarities with the transfer of plasma lipoproteins into the aortic wall of cholesterol-fed rabbits and also with the transfer of other plasma macromolecules across various capillaries. The cholesterol content in intima-media tissue without lesions corresponded in some of the patients to less than one year of continuous influx of cholesteryl ester from plasma. This time is short compared with the age of the patients. It suggests that removal of cholesterol from the aortic wall represents a major importance in prevention of cholesterol accumulation in that tissue.
最近,通过对接受主动脉重建手术的患者使用标记胆固醇,已能够测量胆固醇酯从血浆进入人主动脉组织的体内通量。对于无可见动脉粥样硬化病变的升主动脉,通量为4.5±1.4 nmol·cm⁻²·天⁻¹(均值±标准误,n = 9)。对于有严重动脉粥样硬化的腹主动脉,胆固醇酯的通量为45±5 nmol·cm⁻²·天⁻¹(n = 12)。与血浆中这些脂蛋白组分的浓度相比,在这两种组织中,高密度脂蛋白(HDL)来源的胆固醇酯通量比低密度脂蛋白(LDL)和极低密度脂蛋白(VLDL)来源的胆固醇酯通量高2至3倍。这与一种主动脉通量机制相符,该机制取决于血浆中脂蛋白的大小和浓度。血浆脂蛋白向人主动脉组织的转运与血浆脂蛋白向胆固醇喂养兔子的主动脉壁的转运以及其他血浆大分子跨各种毛细血管的转运有许多相似之处。在一些患者中,无病变的内膜 - 中膜组织中的胆固醇含量相当于血浆中胆固醇酯连续流入不到一年的量。与患者年龄相比,这段时间较短。这表明从主动脉壁清除胆固醇在预防该组织中胆固醇积累方面具有重要意义。